Quick Answer
OptimizeRx Corp reported Cash And Cash Equivalents At Carrying Value of $23.37 million for the year ending 2025.
- OptimizeRx Corp showed an increase of +74.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from OptimizeRx Corp's annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), OptimizeRx Corp's Cash And Cash Equivalents At Carrying Value has grown by 1,728.1%.
- Historical annual values: Fiscal year 2025: $23.37 million | Fiscal year 2024: $13.38 million | Fiscal year 2023: $13.85 million | Fiscal year 2022: $18.21 million | Fiscal year 2021: $84.68 million | Fiscal year 2020: $10.52 million | Fiscal year 2019: $18.85 million | Fiscal year 2018: $8.91 million | Fiscal year 2017: $5.12 million | Fiscal year 2016: $7.03 million | Fiscal year 2015: $8.21 million | Fiscal year 2014: $3.45 million | Fiscal year 2013: $1.12 million | Fiscal year 2012: $284.3 thousand | Fiscal year 2011: $959.2 thousand | Fiscal year 2010: $1.28 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: